Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Nestec SA | 101 |
| 2 | Societe des Produits Nestle SA | 60 |
| 3 | Zevra Therapeutics Inc | 57 |
| 4 | Dow Global Technologies LLC | 54 |
| 5 | Idemitsu Kosan Co Ltd | 48 |
| 6 | SDS Biotech Corp | 34 |
| 7 | Innophos Inc | 22 |
| 8 | 3M Innovative Properties Co | 21 |
| 9 | Centre National de la Recherche Scientifique | 20 |
| 10 | Indian Oil Corp Ltd | 20 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 768 |
| 2 | A61P | Therapeutic activity (drug indications) | 665 |
| 3 | C08G | Polymers from non-vinyl bonds (e.g. polyamides, polyesters) | 365 |
| 4 | C08L | Polymer compositions (blends) | 273 |
| 5 | C07D | Heterocyclic compounds | 219 |
| 6 | A23L | Foods and beverages (general) | 212 |
| 7 | C09D | Coatings, paints, varnishes | 189 |
| 8 | C07C | Acyclic and carbocyclic compounds | 165 |
| 9 | A23V | Foods, foodstuffs - indexing scheme | 139 |
| 10 | C08K | Polymer compositions (additives) | 139 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionWhere research is gaining momentum
Research themes ranked by publication activity show where scientific interest is accelerating around this compound.
| # | Research topic | Papers |
|---|---|---|
| 1 | Bioactive Compounds and Antitumor Agents | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Isao Kubo | University of California, Berkeley | 8 |
| 2 | A. Srinivasa Rao | Vittal Mallya Scientific Research Foundation | 5 |
| 3 | Antonello Mai | Sapienza University of Rome | 5 |
| 4 | Lucia Altucci | University of Naples Federico II | 5 |
| 5 | P. Phani Kumar | Vittal Mallya Scientific Research Foundation | 5 |
| 6 | Gianluca Sbardella | University of Salerno | 4 |
| 7 | R. Paramashivappa | Vittal Mallya Scientific Research Foundation | 4 |
| 8 | Angela Nebbioso | University of Naples Federico II | 3 |
| 9 | Caterina Vicidomini | University of Salerno | 3 |
| 10 | Frank J. Dekker | University of Groningen | 3 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells | 2012 | 562 | Pluripotent Stem Cells Research |
| Small Molecule Modulators of Histone Acetyltransferase p300 | 2003 | 512 | Ubiquitin and proteasome pathways |
| Characterization of alkyl phenols in cashew (Anacardium occidentale) products and assay of their antioxidant capacity | 2005 | 362 | Phytochemicals and Antioxidant Activities |
| Ginkgolic Acid Inhibits Protein SUMOylation by Blocking Formation of the E1-SUMO Intermediate | 2009 | 346 | Cancer-related Molecular Pathways |
| Anacardic acid (6-nonadecyl salicylic acid), an inhibitor of histone acetyltransferase, suppresses expression of nuclear factor-κB–regulated gene products involved in cell survival, proliferation, invasion, and inflammation through inhibition of the inhibitory subunit of nuclear factor-κBα kinase, leading to potentiation of apoptosis | 2008 | 262 | Ginkgo biloba and Cashew Applications |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular composition of this compound?
Which organizations hold the most patents involving this compound?
What research areas are most represented in patent filings for this compound?
What are the leading academic contributors to research on this compound?
How has patent activity evolved in recent years?